Healthcare-Associated Infections Secondary to Multidrug-Resistant Organisms in Hospitalised Patients with COVID-19 Pneumonia: A single-centre experience
Sultan Qaboos University Medical Journal · 02.05.2025 · 25 (1) · 186-190
DOI: 10.18295/2075-0528.2826 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sultan Qaboos University Medical Journal, online erschienen am 02.05.2025. Verfasst von Yahyia Al Hanashi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Program, Oman Medical Specialty Board, Muscat, Oman. Hauptthemen laut MEDLINE: COVID-19, Drug Resistance, Multiple, Bacterial, Cross Infection, Healthcare-Associated Pneumonia. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Objectives
Hospitalisations related to COVID-19 pneumonia have increased the risk of healthcare-associated infections (HCAIs), including those caused by multidrug-resistant organisms (MDROs). This study aimed to investigate the epidemiology of HCAIs secondary to MDROs among hospitalised patients with COVID-19 pneumonia.
Methods
This retrospective study population included patients with COVID-19 pneumonia aged 18 years and older who were admitted to Sultan Qaboos University Hospital, Muscat, Oman, for more than 48 hours between March 2020 and December 2021.
Results
A total of 486 patients were included in this study. Among the cohort, 76 patients (15.6%) were diagnosed with concurrent HCAIs with an MDRO as the causative pathogen. Of these patients, 31 (40.8%) had infections caused by MDR Acinetobacter baumannii, 15 (19.7%) had infections secondary to carbapenem-resistant Klebsiella pneumoniae and 8 (10.5%) had infections caused by extended-spectrum betalactamase Escherichia coli. Pneumonia and bacteraemia were the two most common concurrent healthcare-associated MDRO infection sites, accounting for 42% and 36% of all events, respectively. Among the 486 patients, 155 died (31.9%). Among these, 64 (41.3%) had concurrent HCAIs caused by 1 or more MDROs. Contrarily, among the 331 patients with COVID-19 pneumonia who recovered, only 12 (3.6%) had concurrent HCAIs.
Conclusions
There is high prevalence of healthcare-associated MDRO infections.predominantly pneumonia and bacteraemia.in hospitalised patients with COVID-19 pneumonia. This reveals a significant association between infection with MDROs and death underlining the substantial impact of infection with MDROs in this vulnerable patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine Program, Oman Medical Specialty Board, Muscat, Oman.
- Infectious Diseases Unit, Department of Medicine, Sultan Qaboos University, Muscat, Oman.
Zitieren
APA
Al Hanashi, Y., & Balkhair, A. (2025). Healthcare-Associated Infections Secondary to Multidrug-Resistant Organisms in Hospitalised Patients with COVID-19 Pneumonia: A single-centre experience. Sultan Qaboos University Medical Journal, 25(1), 186-190. https://doi.org/10.18295/2075-0528.2826
Vancouver
Al Hanashi Y, Balkhair A. Healthcare-Associated Infections Secondary to Multidrug-Resistant Organisms in Hospitalised Patients with COVID-19 Pneumonia: A single-centre experience. Sultan Qaboos University Medical Journal. 2025;25(1):186-190. doi:10.18295/2075-0528.2826
BibTeX
@article{AlHanashi2025,
author = {Al Hanashi, Yahyia and Balkhair, Abdullah},
title = {Healthcare-Associated Infections Secondary to Multidrug-Resistant Organisms in Hospitalised Patients with COVID-19 Pneumonia: A single-centre experience},
journal = {Sultan Qaboos University Medical Journal},
year = {2025},
volume = {25},
number = {1},
pages = {186--190},
doi = {10.18295/2075-0528.2826}
}
EUVIMED